PHARMACOKINETICS AND SAFETY OF THE ANTI-HUMAN CYTOMEGALOVIRUS DRUG LETERMOVIR IN SUBJECTS WITH HEPATIC IMPAIRMENT Article Kropeit D., McCormick D., Erb-Zohar K., Moiseev V.S., Kobalava Z.D., Stobernack H.-P., Zimmermann H., Rübsamen-Schaeff H. British Journal of Clinical Pharmacology. Blackwell Publishing Ltd. Vol. 83. 2017. P. 2678-2686
PHARMACOKINETICS OF SERELAXIN IN PATIENTS WITH HEPATIC IMPAIRMENT: A SINGLE-DOSE, OPEN-LABEL, PARALLEL GROUP STUDY Article Kobalava Z., Villevalde S., Kotovskaya Y., Hinrichsen H., Petersen-Sylla M., Zaehringer A., Pang Y., Rajman I., Canadi J., Dahlke M., Lloyd P., Halabi A. British Journal of Clinical Pharmacology. Blackwell Publishing Ltd. Vol. 79. 2015. P. 937-945